KBW Believes DR Horton (NYSE: DHI) Won’t Stop Here

By Austin Angelo

KBW analyst Jade Rahmani reiterated a Buy rating on DR Horton (NYSE: DHI) yesterday and set a price target of $38. The company’s shares closed yesterday at $33.29, close to its 52-week high of $34.56.

According to TipRanks.com, Rahmani is a 4-star analyst with an average return of 10.7% and a 72.9% success rate. Rahmani covers the Financial sector, focusing on stocks such as Starwood Property Trust, Jones Lang Lasalle Inc, and Altisource Residential.

Currently, the analyst consensus on DR Horton is Moderate Buy and the average price target is $34.50, representing a 3.6% upside.

In a report issued on May 22, RBC Capital also reiterated a Buy rating on the stock with a $37 price target.

Based on DR Horton’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $3.25 billion and quarterly net profit of $229 million. In comparison, last year the company earned revenue of $2.77 billion and had a net profit of $195 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

D.R. Horton, Inc. operates as a national homebuilder that engages in the construction and sale of single-family housing. It operates through the Homebuilding and Financial Services segments. The Homebuilding segment includes the sub-segments East, Midwest, Southeast, South Central, Southwest and West regions. The Financial Services segment provides mortgage financing and title agency services to homebuyers in many of its homebuilding markets. The company was founded by Donald Ray Horton in 1978 and is headquartered in Fort Worth, TX.